Dr. Regina Rabinovich is director of the Global Health Program’s Infectious Diseases Development team. She oversees the development and implementation of strategies for the prevention, treatment, and control of diseases of particular relevance to global health, including HIV/AIDS, tuberculosis (TB), malaria, pneumonia, diarrhea, and neglected diseases.
Prior to joining the foundation, Rabinovich served in various positions at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines. She participated in the Children's Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world, and served as liaison to the National Vaccine Program Office, focusing on vaccine safety and vaccine research. As chief of the Clinical and Regulatory Affairs Branch of the Division of Microbiology and Infectious Diseases, she managed the evaluation of candidate vaccines through a network of U.S. clinical research units. During her tenure as branch chief, the units completed large multi-center trials of pertussis and influenza vaccines as well as a number of phase I trials of platform technologies, such as an edible vaccine and vaccines for malaria and rotavirus.
In 1999, Rabinovich became director of the PATH Malaria Vaccine Initiative, a project funded by the foundation to advance efforts to develop promising malaria vaccine candidates. She serves on the boards of several organizations focused on global health and infectious diseases, including the Global Fund for AIDS, TB & Malaria; the NIAID Council; Medicines for Malaria Venture; PATH Vaccine Solutions; and the Institute of One World Health.
Rabinovich received her medical degree from Southern Illinois University and her Master of Public Health degree from the University of North Carolina in Chapel Hill. She joined NIAID's Epidemiology Training Program as a fellow in 1988.
